Long-Term Assets: The sum of all assets classified as non-current.
Edwards Lifesciences Corporation (EW) had Long-Term Assets of $6.96B for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$6.07B |
|
$1.07B |
|
$1.33B |
|
$4.73B |
|
$4.80B |
|
$1.26B |
|
$8.70M |
|
$1.27B |
|
$1.42B |
|
$1.06B |
|
$1.06B |
|
$1.07B |
|
$1.23B |
|
$1.26B |
|
$1.42B |
|
584.80M |
|
585.80M |
|
$1.84 |
|
$1.83 |
|
| Balance Sheet Financials | |
$6.74B |
|
$1.81B |
|
|
Long-Term Assets |
$6.96B |
$13.70B |
|
$1.81B |
|
$598.30M |
|
$1.55B |
|
$3.36B |
|
$10.34B |
|
$7.44B |
|
$10.34B |
|
580.70M |
|
| Cash Flow Statement Financials | |
$1.60B |
|
$-712.90M |
|
$-956.80M |
|
$3.06B |
|
$2.94B |
|
$-119.30M |
|
$158.10M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
3.72 |
|
-- |
|
-- |
|
0.05 |
|
0.06 |
|
78.01% |
|
20.84% |
|
20.84% |
|
23.42% |
|
20.98% |
|
17.69% |
|
$1.33B |
|
-- |
|
-- |
|
-- |
|
0.44 |
|
1.18 |
|
6.65 |
|
54.87 |
|
10.22% |
|
14.19% |
|
7.71% |
|
9.66% |
|
$17.80 |
|
$2.28 |
|
$2.72 |
|